Chimerix — Company Overview, News & Financial Data

Chimerix (NASDAQ:CMRX) is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for life-threatening diseases caused by viruses and cancer. With a commitment to innovation, Chimerix aims to improve outcomes for severely ill patients and their families by providing novel treatments. The company's pipeline is diversified, including antiviral compounds and new oncology therapies. Among its key projects is the development of brincidofovir, an antiviral intended for the treatment of smallpox, highlighting its dedication to addressing global health threats. Chimerix’s objective revolves around leveraging its proprietary technology to deliver first-in-class and best-in-class medicines, aiming to transform the therapeutic landscape for patients in dire need of effective treatments.